Creon

(redirected from pancrelipase)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

Creon

(krē`ŏn), a name given to several minor legendary Greek kings. In the legend of Oedipus, Creon is the brother of Jocasta and after the death of Oedipus' sons becomes king of Thebes. In Euripides' Medea, Creon is the king of Corinth and is murdered by the vengeful Medea. Apollodorus portrays him as an early king of Thebes who purifies Amphitryon after the murder of his uncle.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/

Creon

victim of his own harsh tyranny. [Gk. Lit.: Antigone]
See: Irony

Creon

rules Thebes with cruel decrees. [Gk. Lit.: Antigone]
See: Tyranny
Allusions—Cultural, Literary, Biblical, and Historical: A Thematic Dictionary. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
Pancrelipase: An evidence-based review of its use for treating pancreatic exocrine insufficiency.
A delayed-release capsule formulation of pancrelipase, which will be marketed as Ultresa, has been approved for the treatment of exocrine pancreatic insufficiency caused by cystic fibrosis or other conditions in children and adults.
Solvay Pharmaceuticals removed DBP from its new FDA-approved formulations of pancrelipase capsules in April 2009.
Only fragments of pancreatin and pancrelipase are absorbed systematically.
What is the name associated with porcine of Pancrelipase which break down pancreatic enzymes to treat pancreatic insufficiency?
AbbVie, a research-based biopharmaceutical company, has launched new, higher-dose of Creon (pancrelipase) delayed-release capsules in the United States, it was reported on Friday.
(TSE: 4523) announced today that they have received approval to market the pancreatic enzyme replacement drug Lipacreon(R)(pancrelipase) in Japan as a pancreatic digestive enzyme replacement in patients with pancreatic exocrine insufficiency (PEI).
A pancrelipase that is a combination of lipases, proteases, and amylases--derived from the pancreatic tissue of pigs--was approved for treating exocrine pancreatic insufficiency due to cystic fibrosis or other conditions for adults, children, and infants.
PHILADELPHIA -- Global Pharmaceuticals, the multisource products marketing division of IMPAX Laboratories Inc., currently markets 15 products, including terbutaline sulfate tablets (available exclusively from Global) and the full Lipram line of pancrelipase tablets and capsules.